Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
A Prospective Study for Pleural Lavage Cytology in Patients With Esophageal Cancer
Fudan University
385 participants
Jul 18, 2022
OBSERVATIONAL
Conditions
Summary
Disease recurrence and metastasis are common after curative treatment for patients with esophageal cancer. Thus, it is important to identify the risk factors to predict disease recurrence and metastasis. Pleural lavage cytology (PLC) is reported to be associated with disease recurrence and patient survival in lung cancer, but the value is unclear in esophageal cancer. The aim of this study is to evaluate the value of PLC in esophageal cancer patient in terms of frequencies, association with patient survival, and efficacy of postoperative treatment.
Eligibility
Inclusion Criteria4
- esophageal cancer with histological confirmation before treatment.
- resectable esophageal cancer with clinical T1-4a/N0-3/M0 staging
- potential R0 resection
- no history of other malignancies
Exclusion Criteria3
- severe major organ dysfunction (American society of anesthesiologisits score \>3 )
- patients underwent ESD or EMR
- pleural lavage is unavailable due to adhesions
Interventions
pleural lavages before tumor resection and after tumor resecion, respectively
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05443841